RSS Content

AtriCure Announces Upcoming Investor Conference Schedule

MASON, Ohio--(BUSINESS WIRE)--Oct. 24, 2016-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Stifel Healthcare Conference at the Lotte New York Palace Hotel in New York City on Tuesday, November 15, 2016. Management is scheduled to present at 9:30 a.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure’s corporate website at www.atricure.com. A replay of the presentation will be available for 90 days following the presentation.

AtriCure management will also be presenting at the Canaccord Medical Technologies & Diagnostics Forum at the Westin Grand Central in New York City on Thursday, November 17, 2016. Management is scheduled to present at 2:00 p.m. Eastern Time. A live audio webcast of the presentation may be accessed by visiting the Investors page of AtriCure’s corporate website at www.atricure.com. A replay of the presentation will be available for 90 days following the presentation.

About AtriCure, Inc.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 75,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Source: AtriCure, Inc.

AtriCure, Inc.
Andy Wade
Senior Vice President and Chief Financial Officer
513-755-4564
awade@atricure.com
or
Investor Relations
Lynn Pieper Lewis
Gilmartin Group
415-937-5402
lynn@gilmartinir.com